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Building on Hope or Tackling Fear? Policy Responses to the Growing Costs of
Alzheimer’s Disease and Other Dementias
Abstract
In most countries, it is clear that the costs of care, treatment, and support of people with Alzheimer’s
disease and other dementias will rise considerably in the next few decades. This paper discusses
dementia as an economic concern and looks at the policy questions addressed by the current literature
on the costs of dementia. It then considers the policy responses to concerns about the growing cost of
dementia, distinguishing between ‘hopeful’ policies that seek to reduce or contain the costs, and policies
to address the capacity of the health, care, and social protection systems to respond to dementia care in
a way consistent with public expectations. We conclude that the costs of dementia care do not
necessarily equate to dementia care being unsustainable, but they do highlight the need for policy action.
Additionally, it is relatively easier for policymakers to adopt ‘hopeful’ policies, such as investment in
research to find a disease modifying treatment for Alzheimer’s or strategies for dementia risk reduction,
than it is to tackle the more politically complex decisions needed to ensure that health, care, and social
protection systems have the capacity to respond to the challenge of dementia.
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Chapter 9

Building on Hope or Tackling Fear?
Policy Responses to the Growing Costs of Alzheimer’s Disease
and Other Dementias
Adelina Comas-Herrera

Dementia is a syndrome caused by a collection of progressive illnesses associated with an ongoing decline of brain function. The most common forms
of dementia are Alzheimer’s disease and vascular dementia. Symptoms vary
somewhat by disease, but generally they involve changes in cognition, personality, and behavior, and people at the more severe stages require high
levels of care and support, resulting in large costs.
A huge increase in the numbers of people living longer is a great achievement for humanity, but it has also brought with it important challenges. One
of these is that the numbers of people living with dementia are growing at
a rapid speed and scale. It has been estimated that the number of people
living with dementia worldwide will grow from 46 million in 2015 to 131.5
million by 2050 (Prince et al. 2015), and that the societal costs of dementia
will have reached $1 trillion globally by 2019 (Wimo et al. 2017).

Dementia Policy Choices
There are many reasons why policymakers are paying increasing attention
to dementia. It is a condition with multiple and interdependent impacts:
it can affect people’s ability to live independently, perform self-care tasks,
keep themselves safe, participate in society, continue in the labor market,1
control their own finances; and it also affects others, usually family members, who often provide care and support for very long hours and may give
up or reduce their paid employment in order to provide this care, and whose
own health may be compromised. This multiplicity of impacts also means
that dementia policy spans multiple government departments, and there is
a wide range of stakeholders that can potentially have an interest in, and be
part of, decision-making processes.
Adelina Comas-Herrera, Building on Hope or Tackling Fear?. In: New Models for Managing Longevity Risk.
Edited by Olivia S. Mitchell, Oxford University Press.
© Pension Research Council (2022). DOI: 10.1093/oso/9780192859808.003.0009
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These multiple impacts also mean that there are many policy choices that
can be made to address dementia, including: encouragement (financial,
regulatory, and/or through research infrastructure) in the search for
disease-modifying treatments for the causes of dementia; public health
approaches toward risk reduction; legislation to protect the rights of people living with dementia; reforms to reduce the financial risk associated with
needing (and providing) long-term care for extended periods; policies to
improve health and long-term care system responses; policies to encourage
the development of technological solutions; policies to reduce stigma and
promote the social inclusion of people with dementia; and legal instruments
to address the implications of loss of capacity (Binstock et al. 1992; OECD
2015; WHO 2017; Blank 2019).
An added complexity for policymaking in dementia is that policy decisions must be made in the face of great uncertainty and a relatively weak
evidence base. There is uncertainty, for example, about the nature of the
underlying diseases,2 making it almost impossible to estimate the probability
that investments in finding disease-modifying treatments will be successful.
There is also uncertainty about the future costs of care, which means that
traditional insurance mechanisms may not be suitable if insurers cannot
estimate risks accurately (Barr 2010).
Additionally, the evidence base available to policymakers on dementia
is limited. The health and care programs in most countries lack information systems to identify people with dementia and to allow monitoring of
their situation and outcomes of their care (OECD 2018). In many countries,
governments also lack population surveys providing basic data on, for example, how many people have dementia and how they are being cared for, as
highlighted in the country summaries of the World Alzheimer Report 2016
(Prince et al. 2016). The research evidence base on non-pharmacological
aspects of care treatment and support is weak, particularly for low- and
middle-income countries, although it is improving (Prince et al. 2016; Livingston et al. 2017; WHO 2017; Alzheimer’s Disease International 2018;
Pickett et al. 2018; Salcher-Konrad et al. 2019). Pickett and Brayne (2019)
analyzed dementia research investment between 2011 and 2016 in Canada,
France, Germany, Italy, the United Kingdom (UK), and the United States
(US). They found that, in that period, dementia research spending grew by
nearly 140 percent, reaching 1,374 million euros in 2016, which represented 0.34 percent of the societal costs of dementia in those countries. They
also found that most of this research funding was focused on biomedical
research, with only 4.9 percent of the spending focused on health and social
care research (Pickett and Brayne 2019).
While dementia advocacy groups focus on getting governments to commit to dementia-specific policies, addressing some of the major impacts of
dementia requires policies that are broader in scope. For example, reducing
the risk of dementia at the population level may require addressing
broader economic inequalities. Ensuring better health care for people with
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dementia may require wider reforms of health care systems to improve
the resources available for the management of non-communicable diseases
and chronic conditions. Addressing workforce shortages in dementia is a
key issue for the health and care sectors, and for the economy as a whole.
Addressing the risk that the costs of dementia may be catastrophic requires
addressing the financing of the long-term care system.

Dementia as an Economic Concern
The high costs of dementia are often cited as a motivation for policy action
and used by advocates to draw attention to the condition. For example,
the World Health Assembly’s global action plan on dementia mentions the
financial costs of dementia in its second paragraph (World Health Organization 2017). Advocacy groups have frequently commissioned research
to estimate the costs of dementia: for example, see the Alzheimer’s Society
for the UK (Prince et al. 2014), Dementia Australia (Brown et al. 2017), and
Alzheimer’s Disease International (Prince et al. 2015). An emphasis on high
costs (sometimes referred to as ‘economic catastrophism’) has been particularly strong in the context of making the case for investment in biomedical
research to find a disease-modifying treatment. For example, at an international Dementia Forum event, the US Alzheimer Association CEO, Harry
Johns (2019), was quoted on Twitter as saying, ‘We have increased funding
in dementia research by convincing Congress that the cost of dementia is
not sustainable.’
Economic concerns surrounding dementia have been identified as
including the impact on national economies (in terms of impact on government spending and on economic growth), the impact on individual
finances, and the costs and benefits of different types of care (Keen 1993).
Of course, the economic impact of dementia depends on wider economic trends. Changes in economic growth may affect the amount of public
spending on health and care services, for example following the Great
Recession, and despite growing demand for services, the UK’s public expenditure on adult social care fell in real terms from £22 billion in 2010–2011
to £20.23 billion in 2014–2015 (Bottery et al. 2019). Changes in labor markets will also shape the capacity to respond to dementia: in many countries,
there are already major difficulties in the recruitment of health and social
care workforce, and these difficulties are expected to become much larger
in the near future (OECD 2016).

Dementia Costs and Sustainability
It is common to see academic articles and advocacy arguing that, because
the costs of dementia are high and expected to grow substantially, they
are unsustainable. Yet equating high (and growing) costs with being
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unsustainable is incorrect, as sustainability does not depend on the size of
costs alone.
Thomson et al. (2009), when discussing the sustainability of health
financing, argue that spending on care would be economically sustainable up
to the point at which the societal costs of care exceed the value produced
by that expenditure. So, if spending on dementia care sufficiently threatened other valued areas of economic activity, then dementia care would
be considered to be economically unsustainable. They also discuss fiscal
and political sustainability. Fiscal sustainability relates specifically to public
expenditure and how that compares to public revenue. Thomson et al. further explain that fiscal sustainability can typically be addressed in three ways:
(1) increasing public revenue to meet the desired level of public spending
on care; (2) reducing public spending to the level that can be met by public revenue; and (3) improving the capacity of the care systems to convert
resources into value. From a political perspective, sustainability requires that
the way in which the government allocates public resources is in line with
voters’ expectations. From this political sustainability perspective, it could
even be argued that current public spending on care for people with dementia is too low in many countries, particularly for social care in the UK, where
there appears to be a consensus on the need for long-term care financing
reform to increase the role of public funding, even if political consensus
remains elusive as to the shape of this reform.
It is also interesting to observe that many who seek to emphasize the scale
of the costs of dementia present estimates of the societal costs of dementia
(which include the opportunity costs of unpaid care) as a percentage of
gross domestic product (GDP), when GDP only includes formal (paid) economic activity. The correct comparison, between the percentage of GDP
and the formal costs of care, would be less dramatic.3
In practice, economists have often drawn attention to the fact that formal
costs of health and social care in relation to dementia are only a relatively
small part of GDP. For example, a US report from 1991 entitled ‘Alzheimers:
Could It Bankrupt the Health-Care System?’ included an interview with
Joshua Wiener, who had carried out estimates of future long-term care
expenditure:
Joshua Wiener, a long-term care specialist with the Urban Institute’s Health
Policy Center in Washington, is sceptical of claims that more Alzheimer’s cases
will cripple the health-care system. He estimates inflation-adjusted spending on
long-term care will roughly double from 1993 and 2018, from $75.5 billion to
$168.2 billion, adjusted for inflation. But, assuming modest economic growth,
that will only account for about 2.2 percent of the gross domestic product. ‘It’s
a sizable increase, but I don’t know if it’s the end of civilization as we know it,’
Wiener says.
(Bettelheim 1991)
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Dementia Workforce and Sustainability
Concerns about sustainability of dementia care are also expressed in relation to the future availability of formal health and social care workers and
unpaid carers (OECD 2015). In most middle- and high-income countries,
the population who would traditionally be of working age is rapidly decreasing in size compared to those needing care due to dementia or other
age-related conditions. While in other sectors it is expected that automation will help reduce demand for labor, it is unlikely that this will happen to
a significant extent in the care of people with dementia (Knapp et al. 2015;
Pissarides 2018; Goodhart and Pradhan 2020).
As Goodhart and Pradhan (2020) explain, there is also a risk that large
increases in the population that require care will require the redirection
of an already shrinking labor force toward providing care. As the care sector is considered to have little potential for productivity growth, a shift
of labor toward this sector would be expected to result lower productivity
growth (Ngai and Pissarides 2007; Pissarides 2018). Nevertheless, automation means that there are many jobs in other sectors that will cease to exist.
Pissarides (2018: 4) argues that the pay and social respect of jobs in the care
and services sectors will need to change so that they become ‘good jobs’ if
society is to win the ‘war against the robots.’

Other Potential Economic Impacts of
Dementia
There are other effects of dementia on the economy that can, at least in part,
be attributed to the ways in which care systems are financed and organized.
The first is that the absence of well-functioning collective mechanisms to
pool the risk of incurring high costs of care as a result of dementia or other
conditions may generate distortions in financial planning. Individuals may
oversave, in an attempt to make sure that they have enough savings to cope
with the highest possible costs of dementia, and reduce their consumption
(Barr 2010), or people may put themselves at financial risk by spending
down their savings and assets in order to qualify for public care where these
are means-tested.
Another outcome that can result from the insufficient availability of good
quality, affordable formal care and strong social norms, is the pressure on
women to reduce or give up their employment when a relative requires
care. As the educational attainment and labor force participation of women
increases, the opportunity costs of women giving up paid work in order to
provide care grow. This means that lack of opportunities to stay in the labor
market by not being able to obtain replacement care (see Brimblecombe
et al. 2018) may increasingly result in an inefficient use of human capital.
As Korfhage (2019) shows in his analysis of the impact on lifetime earnings
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and social insurance entitlements of carers who have left employment in
Germany, the opportunity costs are much higher at younger ages and at
the higher end of the income distribution.

How Much Does Dementia Cost, and How
Much Will It Cost in the Future?
There is no standardized methodology on how to estimate the present and
future costs of dementia, and studies that produce these estimates do not
always seek to answer the same research and policy questions. In practice,
because demographic change is driving projected costs, most projection
studies find that the costs of dementia will double or treble over the next 20
or 30 years. For example, in England, the costs of dementia have been projected to rise from £23 billion in 2015 to £80.1 billion by 2040, an increase of
nearly 250 percent (Wittenberg et al. 2020). Globally, the costs of dementia
were estimated to grow from $818 billion in 2015, to $1 trillion by 2018 and
$2 trillion in 2030 (Wimo et al. 2017).
These projection models usually use as a baseline a cost of dementia
study which, typically, seeks to include all the costs of dementia to society,
the direct costs of medical and long-term care services, and at least some
indirect costs (usually estimates of the costs of unpaid care) (Wimo et al.
2017; El-Hayek et al. 2019; Wittenberg et al. 2019). A recent review by ElHayek et al. (2019) set out to consider all the potential costs of dementia
and the methodological difficulties in properly measuring them. This work
suggested that, in practice, most studies leave out significant costs, such as,
for example, the costs of care for the period before dementia is diagnosable.
While differences in the methodologies used in projections of dementia
costs studies are often due to data limitations, an important source of differences is also the fact that each poses different research and policy questions.
This section considers five policy questions that may be answered using models of future costs of dementia and gives some examples of studies that have
sought to address them:

What resources are needed to ensure that the
availability of care matches expected changes in
demand, and what resources are needed to deliver
improved care, treatment, and support?
Most cost of dementia studies fall into this group. They usually measure the
impact of demographic change, and sometimes also of expected epidemiological changes, on the future demand for care, treatment, and support
for people who have dementia. They usually implicitly assume that the unit
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costs of care will rise in line with wages, and that this will guarantee that the
supply of services will increase to meet demand (Wittenberg et al. 1998).
The studies may also investigate the impact of other expected changes, for
example, in the expected supply of unpaid care, improvements in access
to care, and, in some cases, the impact of different ways of financing care.
These studies increasingly attempt to take a societal approach by including
the costs of unpaid care. Many of these studies highlight the increase in
resources needed by reporting the costs of formal medical and long-term
care as a percentage of GDP. In England, for example, it was estimated that
the health and social care costs for people with dementia would rise from
0.8 percent of GDP in 2015 to 1.9 percent in 2040 (Wittenberg et al. 2019).
It has been estimated that, globally, 40 percent of the costs of dementia
are due to unpaid care, 40 percent to formal long-term care services, and
20 percent to medical care (Wimo et al. 2018). Yet, it is difficult to compare the fractions across studies, due to differences in methods and data
used (particularly to estimate the costs of unpaid care), and also due to
different definition of boundaries between types of expenditure (particularly between medical/health care and long-term/social care). Relatively
few studies report on the balance between publicly and privately financed
care.

What would be the impact of new dementia treatments
and prevention strategies?
Simulation models can be used to estimate the costs impact of a modifying
treatment for Alzheimer’s disease and other forms of dementia, or of successful risk reduction strategies. This has led to an increase in models based
on studies that aim to separate the costs of care, treatment, and support
attributable to dementia from costs that are due to other conditions, usually by comparing the service use of people with dementia to those of the
same age and gender who do not have the disease (Hurd et al. 2013; White
et al. 2019). One difficulty with these models is that usually they implicitly
assume that the risk of developing dementia is independent from the risk
of having other health conditions, an assumption that is not well-supported
by epidemiological evidence (Bunn et al. 2014).
As the effects (and costs) of possible new drug treatments are not yet
known, the models that simulate their impact are hypothetical, but they
can be used, for example, to estimate the maximum price at which, given
certain assumed effects, the new drugs would be cost-effective (Anderson
et al. 2018).
When estimating the impact of changes in the course of the diseases, it
is possible that new treatments and prevention strategies for Alzheimer’s
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disease may result in increased longevity and could eventually lead to higher overall health and care costs, particularly if they slow progression. For
example, a simulation model in the US showed that reducing the incidence of some of the risks that have been identified as being associated with
dementia, such as diabetes and hypertension, could eventually lead to higher numbers of people living with dementia as a result of increased longevity
(Zissimopoulos et al. 2018).

What will be the fiscal implications of dementia?
There are relatively few studies that specifically analyze the fiscal implications of dementia. The ones that do typically estimate the projected costs
of the benefits paid out by the social insurance system as a result of dementia under current entitlement rules, and then they compare these to the
projected growth in insurance contributions. As a result of these analyses,
recommendations can be made to address the sustainability of the social
insurance system which may result in increases in the social insurance contributions or the proportion of the costs of care met by taxes. Examples are
analyses that were carried out to assess the implications of a major reform of
the German long-term care insurance system in 2017, which extended the
coverage to include dementia as a result of consensus that existing eligibility
criteria left out people with dementia and also that the levels of benefits were
too low. The reform increased access to benefits for people with dementia
and the size of the benefits available to them, but it also increased the contribution rates to 2.55 percent of gross income (Häcker et al. 2009; Doetter
and Rothgang 2017; Mosca et al. 2017; Nadash et al. 2018).
Analyses of fiscal sustainability will not usually focus on dementia specifically, but its costs will be included in, for example, long-term forecasts of
public spending, as in the UK’s Office for Budget Responsibility (2018)
report. The European Commission regularly produces a report on aging
which analyzes the fiscal impact of public spending on aging-related programs (European Commission Economic Policy Committee 2018). The
European Commission’s analyses show that, while demography is an important driver of future costs of care, the generosity of the public system is an
even more important determinant of future costs.
While most of the debate on sustainability focuses on the costs of publicly
funded services, there is increasing awareness of the fiscal impact of the
provision of unpaid care (particularly where carers withdraw or reduce
their involvement in the labor market). Pickard et al. (2018) estimated that
the public expenditure costs of carers leaving employment in England in
2015/2016 amounted to £2.9 billion a year (£1.2 in forgone taxes and £1.7
in benefits claimed). This did not include the longer term impact of workers’ difficulties returning to employment when the care episode ended. The
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cost of publicly funded formal long-term care in England in the same year
was estimated to be £15.3 billion (Wittenberg and Hu 2015). In Germany,
Korfhage (2019) has analyzed the fiscal implications of reduced tax and
social insurance contributions as a result of unpaid carers withdrawing from
the labor market: he showed that they then faced labor market frictions
when they attempt to rejoin the labor market when the care episode ended.

What will be the impact of dementia on the economy?
A recent study for different regions in Japan suggests that the impact of
labor market reductions as a result of dementia and stroke (due to people
of working age developing these conditions and to unpaid carers withdrawing from the labor market) amounted to one percent of GDP. The impact
was slightly mitigated in regions with higher investment in research and
development (R&D) and higher private capital stock (Taghizadeh-Hesary
et al. 2020).

What is the financial impact of dementia at individual or
family level?
The lifetime costs of dementia, from diagnosis to the end of life, have been
estimated to amount to $321,780 in 2015 US dollars. Of these, 70 percent
were costs incurred by families, 14 percent by Medicaid, and 16 percent by
Medicare (Jutkowitz et al. 2017). In the absence of strong mechanisms to
share the risk of high costs of dementia among the population, these costs
can have a very significant effect on a family’s wealth and amplify economic
inequalities. For example, Kaufman et al. (2018) estimated that, in the US,
dementia was associated with a loss of 97 percent of wealth among black
Americans compared with a 42 percent loss among non-black Americans.
Their study did not find substantial differences in loss of wealth between
families unaffected by dementia.
Unpaid carers who have left employment also face significant lifetime
costs, in the US, Skira (2015) estimated that, for women in the mid-50s who
exited work to provide care for a parent for two years, the median forgone
income was $51,780.

Responding to Dementia as an Economic
Concern
Policy responses to concerns about the growing economic costs of dementia
can be broadly classified into two categories: policies to try to reduce or
contain the costs of care (which could be considered hopeful policies), and
policies to ensure that health, long-term care, and social protection systems
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can deliver levels of care and protection from risk that are in line with social
expectations (policies to reduce fears).

Policies to attempt to reduce or contain the costs of care
These policies seek to reduce the size of the challenge posed by dementia, through a hopeful vision of future success in biomedical research,
healthy aging, technological innovation, and the adoption of cost-saving
interventions.
Such policies may be particularly appealing to policymakers because
research into new treatments and risk reduction policies hold the promise
of a future free of one of the most feared health conditions (Bond et al.
2005; Kessler et al. 2012; Peel 2014; Burke 2017; Evans 2018; Alzheimer’s
Disease International 2019). Also, the hope that investment in R&D will
have positive outcomes contributing to economic growth can play a role in
such policies finding favor with policymakers. Particularly in times of austerity, policymakers may also see these policies as a way to avoid having to
make more difficult policy decisions such as, for example, addressing the
financing of chronic health care and long-term care.
The evidence base for cost-effective (and even some cost-saving) care,
treatment, and support interventions is growing (Knapp et al. 2013; NICE
2018; Nickel et al. 2018). The evidence so far suggests that, for persons living
with dementia, treatment with the existing anti-dementia drugs (Donepezil
and Memantine) (NICE 2018), physical exercise, occupational therapy, and
cognitive stimulation therapy (Knapp et al. 2013; Nickel et al. 2018), some
types of dementia care management (Michalowsky et al. 2019; Vroomen
et al. 2016), and a person-centered care and psychological intervention
for people in nursing homes called WHELD (Ballard et al. 2018) can be
cost-effective. For dyads of persons with dementia and their care partners,
self-management group rehabilitation, and cognitive behavioral therapy are
also cost-effective (Nickel et al. 2018). For carers, a manual-based individual
coping program (START) and an education and support intervention also
seem cost-effective (Nickel et al. 2018).
This evidence base suggests that policymakers can potentially make more
efficient resource allocations by making sure that these cost-effective interventions are made more widely available and, where possible, replace other
interventions and approaches unsupported by evidence.

Policies to increase the capacity for health, long-term
care, and social protection systems to respond to
dementia
Fears around dementia are also linked to the perceived lack of good quality
services to deliver care, treatment, and support; to concerns about being
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a burden to one’s family; and to the fear of losing all savings and assets
(Evans-Lacko et al. 2019). An assessment by the Organisation for Economic
Co-operation and Development (OECD; OECD 2018) concluded that most
OECD countries are poorly equipped to identify dementia, and uncovered
evidence of poor quality of care in most countries, particularly for people
with advanced dementia.
Policies needed to address this issue are wider than dementia, encompassing the medical, long-term care, and social protection sectors. Strong
political champions tend to be required, to build consensus across different political groups and stakeholders, a process which in many countries
can take considerable time. In Germany, the establishment of a mandatory
long-term care insurance system took two decades of political debate before
consensus was eventually reached across all the major political parties, the
unions, employers, and sickness funds as well as private insurers (Götze and
Rothgang 2014). In the UK, potential reforms of the public long-term care
financing system have been under discussion since at least the 1990s.

Tackling the structure of health and care systems
The models for dementia health care predominant in high-income countries and in some low- and middle-income countries, are reliant on the
role of specialist care, but in most countries there are already shortages
of dementia specialists, particularly neurologists, old-age psychiatrists, and
geriatricians (Hlávka et al. 2018). To respond to increasing numbers of people living with dementia, alternative models of dementia health care based
on primary care and specially trained health workers could potentially be
expanded to deliver a consistent quality of care to larger numbers of people,
at a lower cost per person (see Prince et al. 2016).
It is also likely that the models of long-term care delivery that have developed in most high-income countries during the 20th century will need to
change. The sharp divisions between ‘health’ and ‘social’ aspects of care
is becoming increasingly obsolete, particularly as the proportion of older
people with functional dependency but no other chronic conditions is likely to decline while the numbers rise of care users with dementia and three or
more chronic conditions (Kingston et al. 2018). Long-term care systems will
increasingly need to ensure that family and other unpaid carers do not need
to give up their jobs in order to provide care, perhaps through a renewed
focus on models of replacement care and care leave policies (Brimblecombe et al. 2018). This would mirror policy developments seen in relation
to childcare in many countries. There is also growing interest in innovative care models, including new approaches to more attractive daycare
and housing with care models, and better integrated services in the wider
communities.
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Addressing the workforce challenge
The care sector has the opportunity to attract workers that, due to technological change, are no longer able to work in their previous jobs. Yet this
transition will need to be carefully managed, not least because most of those
workers would have experienced higher levels of pay and better working
conditions than those currently working in the care sector.
More innovative approaches to group care may have the potential to
offer more attractive environments both for staff and care users, with the
potential to use at least some economies of scale to deliver care that is more
oriented to rehabilitation and social participation, and better rooted in the
local community.
Tackling the financing of care Without collective risk pooling mechanisms
to cover the whole population for the risk of catastrophic costs of long-term
care as a result of conditions such as dementia, universal health coverage
cannot be achieved. While some countries have been able to offer this
(e.g. the Scandinavian countries), many others have either added long-term
care to existing social health insurance schemes or developed separately
financed long-term care social insurance systems. There are also still a few
high-income countries where there has not been sufficient political and
social support for universal coverage of long-term care needs. Both the UK
and the US have public systems that only cover those lacking the means to
pay for their own care. In the case of the US, those without pre-existing conditions who have high incomes may be able to buy private long-term care
insurance. In the UK, the market for private long-term care insurance is virtually non-existent (Comas-Herrera et al. 2012). At least in the UK, there
is growing recognition that public expectations and public policies on care
are at odds. After many decades of debate on how long-term care funding
should be reformed, there is at least a consensus that reform does need
to happen, even if consensus about the type of reform has not yet been
achieved.

Conclusion
‘Hopeful policies’ that support research on understanding the nature of
the conditions that result in dementia, promote dementia risk reduction,
and encourage technological care innovations have their place. Yet, they
do not remove the need to address the more difficult policy decisions on
how to ensure health, care, and social protection systems can deliver care,
treatment, support, and financial protection for people living with dementia
that is in line with public expectations and preferences.
Many barriers that policymakers encounter when seeking to address
the capacity of care and social protection systems appear to be linked to
concerns about the size of public spending and its potential impact on
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economic sustainability. As this review highlights, the economic impact of
dementia needs to be considered in a wider economic and political context. At a time of increased automation in many other sectors, the care
sector could benefit from policies that facilitate transitions of workers from
other sectors, as well as improving current models of care and adopting
cost-effective interventions.
As the number of people living with dementia grows, so does the number
of people with personal experience of the implications of this condition to
both the individuals themselves and their families. Thus, there is likely to
be increased awareness of the limitations of current health, care, and protection systems. Unless these systems can be made to reflect societal norms
and expectations, they too will become politically unsustainable.

Notes
1. Not all people who develop dementia are over retirement age.
2. Only recently a new form of dementia, LATE, has been identified. This form
appears to mimic Alzheimer’s type dementia and it is suggested that this may
explain why some recent trials for treatments of Alzheimer’s disease have not
been successful (Nelson et al. 2019).
3. For example, Alzheimer’s Disease International’s (2015) infographic that represents the findings of their World Alzheimer’s Report 2015 aims to illustrate the
scale of the societal costs of dementia by stating that ‘If global dementia care
were a country, it would be the 18th largest economy in the world exceeding
the market values of companies such as Apple and Google’ (Alzheimer’s Disease
International 2015).
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